BOSTON PHARMA – VIETNAM TOP BRAND IN 2022

Boston Pharma's Activities • Monday, 26/12/2022 - 13:57 (GMT+7)

Boston Pharma was named the Vietnam Top Brand in 2022 (VietNam Top Brand 2022) by the Asia Business Development Research Center in collaboration with prestigious organizations on December 24, 2022. State leaders and international organizations attended the announcement ceremony. The event broadcast live on VTC6.


Mr Lương Tiến Minh – Deputy General Director of Boston Pharma received the announcement

At the announcement ceremony, the criteria proposed by the Voting Council according to international standards were improved and applied exclusively to enterprises in Vietnam based on six core criteria:

  1. reputable brand and a leading industry in Vietnam.
  2. quality products and services in Vietnam and export markets
  3. sustainable development strategy in Vietnam.
  4. important contribution to Vietnam's economy.
  5. Exercise social and community responsibility.

Over the past 15 years of establishment and development, the company has affirmed its prestige and quality in each product with the motto "Boston Pharma - where finest quality happens" expressed by continuous investment in factories, equipment, machinery, and especially human resources. Besides, Boston Pharma always improves competitiveness and applies good solutions to take aim at sustainable development.

Outstanding achievements that Boston Pharma has achieved:

- Human Resources: More than 1000 employees nationwide

- Sales in 2022 are expected to be nearly VND 1200 billion, exceeding business targets.

- March 2022: Officially licensed to produce and distribute Molravir 400 (active ingredient molnupiravir), indicated for the treatment of COVID-19, manufactured by Vietnamese businesses.

- The company received a GMP-EU certificate from the Food and Drug Administration of Portugal in September 2022 for the line of tablets, film-coated tablets, and hard capsules.

- In November 2022, the Ministry of Science and Technology evaluated and recognized the Science and Technology Enterprise.

- The third factory, with a total area of over 30,000 m2, is scheduled to open in the second or third quarter of 2023. At that time, the production capacity had reached over 3 billion products per year to serve domestic consumption and export. When the 3rd factory operates, Boston Pharma will own a total of 3 GMP factories, 3 GLP laboratories, and a GMP research center upgraded by the R&D department.

- Success in digital transformation when using SAP-S4HANA software in management, the BASE ecosystem, an artificial intelligence (AI)-powered customer care call center, and ROBOT OFFICE for sales accounting, sales administration, and inventory management. As a pioneer in the pharmaceutical industry using the Boston Sale App, Viettel Money Wallet makes it easy for customers to order and pay at home for many utilities. Up to now, Boston Pharma has a sales-delivery system in 63 provinces and cities, including 100 delivery vehicles nationwide, to achieve standards of good practice in drug distribution (GDP).


Simulation of 3 factories

"Boston Pharma prioritizes quality products and services in order to provide the best possible service to customers," said Mr. Luong Tien Minh, Deputy General Director of Boston Pharma. Furthermore, we incorporated technology to promote business advantages. "The enterprise did not prioritize profit and will align economic benefits with customer profits, mirroring human values for the community."

A company not only performs business and production tasks well, but it also employs people. Throughout the COVID-19 pandemic, Boston Pharma has consistently supported the community's infection prevention and control efforts. Many charitable activities have occurred, including the donation of Molravir to Binh Duong Province, the Vietnam Fatherland Front Committee of Ninh Binh Province, and the Central-level Senior Officials Healthcare Service; the sponsorship of scholarships for the Faculty of Medicine at the University of Medicine and Pharmacy in Ho Chi Minh City; the Vietnam National University Ho Chi Minh City - School of Medicine; and the Volunteer Team program "Dong Am 2022."


Boston Pharma – VietNam Top Brand in 2022

Boston Pharma - VietNam Top Brand in Vietnam 2022 validates the ethics, brainpower, and vision of the company's board of directors, as well as all of its young, talented, and enthusiastic employees. This is an excellent result that demonstrates the company's strong position, which has spread not only in Vietnam but also into international cooperation.

Reviews
19001910